Journal article
Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer
R Sreenivasan, L Ludbrook, B Fisher, F Declosmenil, KC Knower, B Croft, AD Bird, J Ryan, A Bashamboo, AH Sinclair, P Koopman, K McElreavey, F Poulat, VR Harley
Human Mutation | WILEY-HINDAWI | Published : 2018
DOI: 10.1002/humu.23603
Abstract
Nuclear receptor subfamily 5 group A member 1/Steroidogenic factor 1 (NR5A1; SF-1; Ad4BP) mutations cause 46,XY disorders of sex development (DSD), with phenotypes ranging from developmentally mild (e.g., hypospadias) to severe (e.g., complete gonadal dysgenesis). The molecular mechanism underlying this spectrum is unclear. During sex determination, SF-1 regulates SOX9 (SRY [sex determining region Y]-box 9) expression. We hypothesized that SF-1 mutations in 46,XY DSD patients affect SOX9 expression via the Testis-specific Enhancer of Sox9 core element, TESCO. Our objective was to assess the ability of 20 SF-1 mutants found in 46,XY DSD patients to activate TESCO. Patient DNA was sequenced fo..
View full abstractGrants
Awarded by John R. Oishei Foundation
Funding Acknowledgements
National Health and Medical Research Council, Grant/Award Numbers: 334314, 546517